QL
ZNTL icon

Quarry LP’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Quarry LP’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$351K Buy
150,000
+18,000
+14% +$46.5K 0.06% 212
2025
Q4 		$178K Buy
132,000
+23,250
+21% +$33.8K 0.03% 290
2025
Q3 		$164K Buy
108,750
+3,750
+4% +$5.62K 0.04% 404
2025
Q2 		$122K Sell
105,000
-15,000
-13% -$19.8K 0.03% 480
2025
Q1 		$191K Buy
120,000
+66,500
+124% +$143K 0.04% 312
2024
Q4 		$162K Buy
53,500
+38,500
+257% +$126K 0.02% 297
2024
Q3 		$55.2K Buy
+15,000
New +$54.5K 0.01% 682

Other funds holding ZNTL

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Quarry LP's ZNTL Position: Q1 2026 in Review

Quarry LP increased its Zentalis Pharmaceuticals (ZNTL) stake by 14% in Q1 2026, buying an estimated $46.5K and bringing the position to 150,000 shares worth $351K. The position accounts for 0.06% of the portfolio, ranked #212.

Quarry LP first reported a position in ZNTL in Q3 2024 and has held it in 7 quarters since. 102 funds tracked by Wall St. Rank hold ZNTL as of Q1 2026.

  • Quarry LP held 150,000 shares of Zentalis Pharmaceuticals worth $351K as of Q1 2026.
  • Quarry LP bought 18,000 Zentalis Pharmaceuticals shares in Q1 2026, an estimated $46.5K.
  • Zentalis Pharmaceuticals made up 0.06% of Quarry LP's portfolio in Q1 2026, its #212 holding.
  • Quarry LP first reported a position in Zentalis Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 102 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.